VP3.15

Modify Date: 2024-01-11 19:49:49

VP3.15 Structure
VP3.15 structure
Common Name VP3.15
CAS Number 1281681-54-6 Molecular Weight 366.48
Density N/A Boiling Point N/A
Molecular Formula C20H22N4OS Melting Point N/A
MSDS N/A Flash Point N/A

 Use of VP3.15


VP3.15 is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. VP3.15 has neuroprotective and neuroreparative activities, thus as potential combined anti-inflammatory and pro-remyelinating therapies for multiple sclerosis (MS)[1].

 Names

Name VP3.15

 VP3.15 Biological Activity

Description VP3.15 is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. VP3.15 has neuroprotective and neuroreparative activities, thus as potential combined anti-inflammatory and pro-remyelinating therapies for multiple sclerosis (MS)[1].
Related Catalog
Target

IC50: 1.59 μM (PDE7), 0.88 μM (GSK-3)[1]

References

[1]. Medina-Rodríguez EM, et al. Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis. Sci Rep. 2017 Mar 3;7:43545.

 Chemical & Physical Properties

Molecular Formula C20H22N4OS
Molecular Weight 366.48